US OptionsDetailed Quotes

CTXR240816C1000

Watchlist

0.17
-0.03-15.00%

15min DelayTrading Jul 26 15:10 ET

0.25High0.15Low

Citius Pharmaceuticals Stock Discussion

Jaguar8

Jul 18 06:02

NEWS

$Citius Pharmaceuticals(CTXR.US)$
Biotech Stocks Race Towards Solutions for Cutaneous T-Cell Lymphoma (CTCL)
Biotech stocks are racing towards solutions for Cutaneous T-Cell Lymphoma (CTCL), with the market projected to reach $1.38 Billion by 2030.
Citius Pharmaceuticals (NASDAQ: CTXR) is approaching the FDA target date of August 13th for its LYMPHIR product candidate.
The FDA has accepted the resubmission of Citius' Biologics License Application (BLA) for LYMPHIR, an IL-2-based immunother...

Trytosaveabit

Jul 15 13:42

Lookadat! Hehehe

$Citius Pharmaceuticals(CTXR.US)$ Already makin a tiny move! Hehehe

Trytosaveabit

Jul 13 07:43

Just a bit more added to my July 10th post!

$Citius Pharmaceuticals(CTXR.US)$ I forgot to include this in my July 10th BOLO post! But the vote on TENKU merger is coming! As of now the vote is scheduled for 8/2/2024. Also the company has been busy preparing to commercially launch LYMPHIR if the recieve FDA approval! I will post again that PDUFA Date is 8/13/2024!

Jaguar8

Jul 11 11:35

NEWS

$Citius Pharmaceuticals(CTXR.US)$
Bloodstream Infections - From Threats to Solutions
Investorideas.com published the second part of a series on blood infections treatment, featuring Citius Pharmaceuticals (NASDAQ: CTXR). Citius has made significant advances in its late-stage product candidates, particularly Mino-Lok® for catheter-related bloodstream infections (CRBSIs). The Phase 3 trial of Mino-Lok® showed positive topline results, meeting primary and secondary endpoints with statistical si...

amiable Hedgehog_758

Jul 11 03:45

$Citius Pharmaceuticals(CTXR.US)$
HC Wainwright & Co. Reiterates Buy on Citius Pharma, Maintains $4 Price Target
Benzinga· May 31 13:061min
Citius Pharmaceuticals (CTXR.US)
0.746
+10.29%
HC Wainwright & Co. analyst Vernon Bernardino reiterates Citius Pharma (NASDAQ:CTXR) with a Buy and maintains $4 price target.
Disclaimer: This content is for inform

amiable Hedgehog_758

Jul 11 03:33

$Volcon(VLCN.US)$
good morning everyone pay attention CTXR next month 4$

amiable Hedgehog_758

Jul 11 03:27

$Citius Pharmaceuticals(CTXR.US)$

amiable Hedgehog_758

Jul 11 03:27

$Citius Pharmaceuticals(CTXR.US)$ every one pay attention late stage going to 4$

Trytosaveabit

Jul 10 14:02

Reminder. Make a note. Well only ifn ya want to? Hehehe

$Citius Pharmaceuticals(CTXR.US)$ Upcoming catalyst for possibly superior gains? So ima share with my pals! Hehehe. • A decision on the LYMPHIR BLA is expected on August 13, 2024, the FDA's assigned Prescription Drug User Fee Act (PDUFA) action date. If approved, Citius is preparing for LYMPHIR commercialization in 2024.
• Considered a new biologic by the FDA, LYMPHIR would potentially be eligible f...

Romez

Jul 9 20:44

$Citius Pharmaceuticals(CTXR.US)$ she looks primed for a 🚀

No comment yet